DAXOR CORPORATION (NYSEMKT:DXR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

DAXOR CORPORATION (NYSEMKT:DXR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Story continues below

Item 5.02

Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

A special meeting was held on Tuesday, February 14, 2017 to elect
a new Chairman and appoint a new member of the Board of Directors
for the Daxor Corporation. This action was necessitated due to
the death of Dr. Joseph Feldschuh, Chairman and a member of the
Board of Directors.

In a unanimous vote Michael Feldschuh was appointed Chairman. Mr.
Feldschuh now holds the titles of Chairman, Chief Executive
Officer, and President of Daxor Corporation. Mr. Feldschuh
abstained from this vote.

Jonathan Feldschuh, Daxors Chief Scientific Officer, was
appointed to fill the member seat vacated by Dr. Feldschuh on
Daxors Board of Directors.


About DAXOR CORPORATION (NYSEMKT:DXR)

Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company engages in the short selling of stock. The Company maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies. It has approximately 70 Blood Volume Analyzers (BVA)-100. It also sells Volumex Kits. The semi-automated BVA provides blood volume measurements in human body, which are fundamental tools for diagnosis and treatment in a range of medical and surgical conditions, including congestive heart failure, hypertension, syncope, anemia in cancer patients, kidney failure and hyponatremia. The BVA-100 measures blood volume in approximately an hour. Its IDANT division provides semen banking services, which include anonymous donor semen and semen storage; autologous blood storage; andrology services, which include semen analysis and sperm washing, and general lab testing.

DAXOR CORPORATION (NYSEMKT:DXR) Recent Trading Information

DAXOR CORPORATION (NYSEMKT:DXR) closed its last trading session 00.00 at 8.64 with 0 shares trading hands.

An ad to help with our costs